The Effects of Lemborexant on the Ability to Sleep During Daytime

Clinical trial NCT06231641 · TERMINATED

Trial details

NCT number: NCT06231641
Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Shift-Work Sleep Disorder

Start date: 2024-01-11
Primary completion: 2026-03-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.